{
    "2019-01-31": [
        [
            {
                "time": "2019-01-31",
                "original_text": "明日最具投资机会六大牛股一览（2019年1月31日）",
                "features": {
                    "keywords": [
                        "投资机会",
                        "牛股"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报:创新药产业链为长期主题,重点推荐恒瑞医药、药石科技",
                "features": {
                    "keywords": [
                        "医药行业",
                        "创新药",
                        "恒瑞医药",
                        "药石科技"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业《关于加强公立医院绩效考核工作的意见》政策点评:腾笼换鸟思路未变,管理精细化促医疗价值回归",
                "features": {
                    "keywords": [
                        "公立医院",
                        "绩效考核",
                        "政策",
                        "腾笼换鸟",
                        "医疗价值"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "迈瑞医疗18年业绩预告点评:业绩符合预期,平台化、高端化、全球化稳步推进",
                "features": {
                    "keywords": [
                        "迈瑞医疗",
                        "业绩预告",
                        "平台化",
                        "高端化",
                        "全球化"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}